幽门螺旋杆菌感染与非酒精性脂肪肝关系的研究进展
The Mechanism of Nonalcoholic Fatty Liver Disease Induced by Helicobacter pylori Infection
摘要: 幽门螺旋杆菌是一种长期定居于消化道的微需氧菌，是人类微生物群的关键组成部分，与胃肠道疾病的发生密切相关。有研究证实，幽门螺旋杆菌可以在非酒精性脂肪肝患者肝内定格。此外，还有研究表示幽门螺旋杆菌感染与非酒精性脂肪肝的发生与发展呈正相关，是非酒精性脂肪肝多重发病机制的一部分。但具体作用机制尚存在争议。通过研究两者之间的关系，可以为临床防治非酒精性脂肪肝提供新思路。本文就幽门螺旋杆菌在非酒精性脂肪肝发生和发展方面的研究进展进行综述。
Abstract: Helicobacter pylori is a kind of long-term settled in the digestive tract of aerobe, is the key component of the human microbiota, linked closely with the incidence of gastrointestinal diseases. Some studies have confirmed that H. pylori can be fixed in the liver of patients with non-alcoholic fatty liver disease. In addition, studies have shown that Helicobacter pylori infection is positively correlated with the occurrence and development of nonalcoholic fatty liver disease, which is a part of the multiple pathogenesis of nonalcoholic fatty liver disease. However, the specific mechanism is still controversial. By studying the relationship between the two, can provide new ideas for clinical prevention and treatment of nonalcoholic fatty liver disease. In this paper, the H. pylori in the occurrence and development of nonalcoholic fatty liver disease research progress were summarized.
文章引用：李婷婷, 马鹏. 幽门螺旋杆菌感染与非酒精性脂肪肝关系的研究进展[J]. 临床医学进展, 2021, 11(9): 3865-3869. https://doi.org/10.12677/ACM.2021.119566

参考文献

[1] Bellentani, S., Scaglioni, F., Marino, M. and Bedogni, G. (2010). Epidemiology of Non-Alcoholic Fatty Liver Disease. Digestive Diseases (Basel, Switzerland), 28, 155-161.[CrossRef] [PubMed]
[2] Chen, L.W., Kuo, S.F., Chen, C.H., Chien, C.H., Lin, C.L. and Chien, R.N. (2018). A Community-Based Study on the Association between Helicobacter pylori Infection and Obesity. Scientific Reports, 8, Article ID: 10746.[CrossRef] [PubMed]
[3] Li, M., Shen, Z. and Li, Y.M. (2013). Potential Role of Helicobacter pylori Infection in Nonalcoholic Fatty Liver Disease. World Journal of Gastroenterology, 19, 7024-7031.[CrossRef] [PubMed]
[4] Waluga, M., Kukla, M., Żorniak, M., Bacik, A. and Kotulski, R. (2015). From the Stomach to Other Organs: Helicobacter pylori and the Liver. World Journal of Hepatology, 7, 2136-2146.[CrossRef] [PubMed]
[5] Kebapcilar, L., Bilgir, O., Cetinkaya, E., Akyol, M., Bilgir, F. and Bozkaya, G. (2010). The Effect of Helicobacter pylori Eradication on Macrophage Migration Inhibitory Factor, C-Reactive Protein and Fetuin-A Levels. Clinics (Sao Paulo, Brazil), 65, 799-802.[CrossRef] 
[6] Polyzos, S.A. and Kountouras, J. (2015). Novel Advances in the Association between Helicobacter pylori Infection, Metabolic Syndrome, and Related Morbidity. Helicobacter, 20, 405-409.[CrossRef] [PubMed]
[7] Satoh, H., Saijo, Y., Yoshioka, E. and Tsutsui, H. (2010). Helicobacter pylori Infection Is a Significant Risk for Modified Lipid Profile in Japanese Male Subjects. Journal of Atherosclerosis and Thrombosis, 17, 1041-1048.[CrossRef] [PubMed]
[8] 刘婷婷, 张颖秋, 朱樑. 幽门螺旋杆菌与肝病的研究进展[J]. 第二军医大学学报, 2016(6): 744-749.
[9] Musso, G., Gambino, R. and Cassader, M. (2009). Recent Insights into Hepatic Lipid Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD). Progress in Lipid Research, 48, 1-26.[CrossRef] [PubMed]
[10] Basso, D., Plebani, M. and Kusters, J.G. (2010). Pathogenesis of Helicobacter pylori Infection. Helicobacter, 15, 14-20.[CrossRef] [PubMed]
[11] Ibrahim, S.H., Kohli, R. and Gores, G.J. (2011). Mechanisms of Lipotoxicity in NAFLD and Clinical Implications. Journal of Pediatric Gastroenterology and Nutrition, 53, 131-140.[CrossRef] 
[12] Castaño-Rodríguez, N., Mitchell, H.M. and Kaakoush, N.O. (2017). NAFLD, Helicobacter Species and the Intestinal Microbiome. Best Practice & Research Clinical Gastroenterology, 31, 657-668.[CrossRef] [PubMed]
[13] Jones, T.A., Hernandez, D.Z., Wong, Z.C., Wandler, A.M. and Guillemin, K. (2017). The Bacterial Virulence Factor CagA Induces Microbial Dysbiosis That Contributes to Excessive Epithelial Cell Proliferation in the Drosophila Gut. PLoS Pathogens, 13, e1006631.[CrossRef] [PubMed]
[14] Schulz, C., Schütte, K., Koch, N., Vilchez-Vargas, R., Wos-Oxley, M.L., Oxley, A., Vital, M., Malfertheiner, P. and Pieper, D.H. (2018). The Active Bacterial Assemblages of the Upper GI Tract in Individuals with and without Helicobacter Infection. Gut, 67, 216-225.[CrossRef] [PubMed]
[15] Porras, D., Nistal, E., Martínez-Flórez, S., Pisonero-Vaquero, S., Olcoz, J.L., Jover, R., González-Gallego, J., García- Mediavilla, M.V. and Sánchez-Campos, S. (2017). Protective Effect of Quercetin on High-Fat Diet-Induced Non-Alco- holic Fatty Liver Disease in Mice Is Mediated by Modulating Intestinal Microbiota Imbalance and Related Gut-Liver Axis Activation. Free Radical Biology & Medicine, 102, 188-202.[CrossRef] [PubMed]
[16] Subramanian, S., Goodspeed, L., Wang, S., Kim, J., Zeng, L., Ioannou, G.N., Haigh, W.G., Yeh, M.M., Kowdley, K.V., O’Brien, K.D., Pennathur, S. and Chait, A. (2011). Dietary Cholesterol Exacerbates Hepatic Steatosis and Inflammation in Obese LDL Receptor-Deficient Mice. Journal of Lipid Research, 52, 1626-1635.[CrossRef] 
[17] Miele, L., Valenza, V., La Torre, G., Montalto, M., Cammarota, G., Ricci, R., Mascianà, R., Forgione, A., Gabrieli, M. L., Perotti, G., Vecchio, F.M., Rapaccini, G., Gasbarrini, G., Day, C.P. and Grieco, A. (2009). Increased Intestinal Permeability and Tight Junction Alterations in Nonalcoholic Fatty Liver Disease. Hepatology, 49, 1877-1887.[CrossRef] [PubMed]
[18] Wieland, A., Frank, D.N., Harnke, B. and Bambha, K. (2015). Systematic Review: Microbial Dysbiosis and Nonalcoholic Fatty Liver Disease. Alimentary Pharmacology & Therapeutics, 42, 1051-1063.[CrossRef] [PubMed]
[19] Fukuda, Y., Bamba, H., Okui, M., Tamura, K., Tanida, N., Satomi, M., Shimoyama, T. and Nishigami, T. (2001). Helicobacter pylori Infection Increases Mucosal Permeability of the Stomach and Intestine. Digestion, 63, 93-96.[CrossRef] [PubMed]
[20] Zhou, B.G., Yang, H.J., Xu, W., Wang, K., Guo, P. and Ai, Y.W. (2019). Association between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Observational Studies. Helicobacter, 24, Article ID: e12576.[CrossRef] [PubMed]
[21] Ouchi, N., Kihara, S., Arita, Y., Okamoto, Y., Maeda, K., Kuriyama, H., Hotta, K., Nishida, M., Takahashi, M., Muraguchi, M., Ohmoto, Y., Nakamura, T., Yamashita, S., Funahashi, T. and Matsuzawa, Y. (2000). Adiponectin, an Adipocyte-Derived Plasma Protein, Inhibits Endothelial NF-kappaB Signaling through a cAMP-Dependent Pathway. Circulation, 102, 1296-1301.[CrossRef] 
[22] Pirouz, T., Zounubi, L., Keivani, H., Rakhshani, N. and Hormazdi, M. (2009). Detection of Helicobacter pylori in Paraffin-Embedded Specimens from Patients with Chronic Liver Diseases, Using the Amplification Method. Digestive Diseases and Sciences, 54, 1456-1459.[CrossRef] [PubMed]
[23] Polyzos, S.A., Kountouras, J., Papatheodorou, A., Patsiaoura, K., Katsiki, E., Zafeiriadou, E., Zavos, C., Anastasiadou, K. and Terpos, E. (2013). Helicobacter pylori Infection in Patients with Nonalcoholic Fatty Liver Disease. Metabolism: Clinical and Experimental, 62, 121-126.[CrossRef] [PubMed]
[24] Cheng, D.D., He, C., Ai, H.H., Huang, Y. and Lu, N.H. (2017). The Possible Role of Helicobacter pylori Infection in Non-Alcoholic Fatty Liver Disease. Frontiers in Microbiology, 8, 743.[CrossRef] [PubMed]
[25] 何周桃, 韩向阳, 陈益耀, 等. 根除幽门螺杆菌在伴幽门螺杆菌感染的非酒精性脂肪性肝病治疗中的应用[J]. 肝脏, 2017, 22(3): 244-247.
[26] 马杈. 根除幽门螺杆菌对非酒精性脂肪性肝病的影响[D]: [硕士学位论文]. 延安: 延安大学, 2017.
[27] 刘畅, 彭刚, 邹瑞政. 非酒精性脂肪性肝病与幽门螺杆菌关系及抗幽门螺杆菌治疗疗效研究[J]. 现代消化及介入诊疗, 2018, 23(5): 636-639.

为你推荐